InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 11.89
+0.14 (1.19%)
May 28, 2026, 9:30 AM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 24.43 billion as of May 27, 2026. Its market cap has increased by 21.10% in one year.
Market Cap
24.43B
Enterprise Value
18.45B
Revenue
2.87B
Ranking
n/a
PE Ratio
23.81
Stock Price
11.89
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 24.43B, an increase of 98.94%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 24.43B | 3.12% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 46.03B |
| Shanghai Junshi Biosciences | 38.80B |
| Shanghai Henlius Biotech | 38.45B |
| Genscript Biotech | 28.38B |
| Duality Biotherapeutics | 20.12B |
| Metis TechBio | 19.45B |
| Keymed Biosciences | 18.50B |
| TransThera Sciences (Nanjing) | 17.31B |